Capricor Therapeutics Stock Probability of Future Stock Price Finishing Under 13.26
| CAPR Stock | USD 14.01 0.12 0.85% |
Capricor |
Capricor Therapeutics Target Price Odds to finish below 13.26
The tendency of Capricor Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 13.26 or more in 90 days |
| 14.01 | 90 days | 13.26 | about 13.76 |
Based on a normal probability distribution, the odds of Capricor Therapeutics to drop to $ 13.26 or more in 90 days from now is about 13.76 (This Capricor Therapeutics probability density function shows the probability of Capricor Stock to fall within a particular range of prices over 90 days) . Probability of Capricor Therapeutics price to stay between $ 13.26 and its current price of $14.01 at the end of the 90-day period is about 5.3 .
Given the investment horizon of 90 days Capricor Therapeutics has a beta of 0.0441 suggesting as returns on the market go up, Capricor Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Capricor Therapeutics will be expected to be much smaller as well. Moreover Capricor Therapeutics has an alpha of 1.8637, implying that it can generate a 1.86 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Capricor Therapeutics Price Density |
| Price |
Predictive Modules for Capricor Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Capricor Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Capricor Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Capricor Therapeutics is not an exception. The market had few large corrections towards the Capricor Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Capricor Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Capricor Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.86 | |
β | Beta against Dow Jones | 0.04 | |
σ | Overall volatility | 3.49 | |
Ir | Information ratio | 0.16 |
Capricor Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Capricor Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Capricor Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Capricor Therapeutics is way too risky over 90 days horizon | |
| Capricor Therapeutics appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 25.18 M. Net Loss for the year was (22.29 M) with profit before overhead, payroll, taxes, and interest of 1.75 M. | |
| Capricor Therapeutics currently holds about 51.42 M in cash with (25.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.11. | |
| Capricor Therapeutics has a very weak financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Dunbar George W Jr of 8310 shares of Capricor Therapeutics subject to Rule 16b-3 |
Capricor Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Capricor Stock often depends not only on the future outlook of the current and potential Capricor Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Capricor Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.8 M | |
| Cash And Short Term Investments | 39.5 M |
Capricor Therapeutics Technical Analysis
Capricor Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Capricor Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Capricor Therapeutics. In general, you should focus on analyzing Capricor Stock price patterns and their correlations with different microeconomic environments and drivers.
Capricor Therapeutics Predictive Forecast Models
Capricor Therapeutics' time-series forecasting models is one of many Capricor Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Capricor Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Capricor Therapeutics
Checking the ongoing alerts about Capricor Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Capricor Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Capricor Therapeutics is way too risky over 90 days horizon | |
| Capricor Therapeutics appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 25.18 M. Net Loss for the year was (22.29 M) with profit before overhead, payroll, taxes, and interest of 1.75 M. | |
| Capricor Therapeutics currently holds about 51.42 M in cash with (25.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.11. | |
| Capricor Therapeutics has a very weak financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Dunbar George W Jr of 8310 shares of Capricor Therapeutics subject to Rule 16b-3 |
Additional Tools for Capricor Stock Analysis
When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.